Tecan Group AG

Tecan Group AG

52.50
USD
0.00
(0.00%)
No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Company News

  • How to Invest in AI Drug Discovery

  • Tecan Group AG (TCGGY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

  • Tecan Group AG (TCGGY) Q2 2026 Earnings Call Transcript

  • Tecan Accelerates Data-Driven Lab Journey With Agentic AI Developments Powered by NVIDIA

  • Tecan to create Data-Driven Labs with NVIDIA

  • Tecan Group AG (TCGGY) Analyst/Investor Day Transcript

  • Tecan Group AG (TCGGY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

  • Cellares Selects Five Best-in-Class Technology Providers, Tecan, Advanced Instruments, Cytek Biosciences, Slingshot Biosciences and AltemisLab, to Expand Cell Q's Capabilities in Meeting Demands for Commercial Scale Cell Therapy Quality Control

  • Tecan Group AG (TCHBF) Q2 2025 Earnings Call Transcript

  • Tecan Group AG (TCHBF) Q4 2024 Earnings Call Transcript

  • Tecan Group AG (TCHBF) Q2 2024 Earnings Call Transcript

  • Tecan appoints Mukta Acharya Head of the Life Sciences Business division

  • Tecan Group AG (TCHBF) Q4 2023 Earnings Call Transcript

  • Tecan Group AG (TCHBF) Q2 2023 Earnings Call Transcript